Title | ACOD1-mediated lysosomal membrane permeabilization contributes to Mycobacterium tuberculosis-induced macrophage death. |
Publication Type | Journal Article |
Year of Publication | 2025 |
Authors | Yang Z, Zhang L, Ottavi S, Geri JB, Perkowski A, Jiang X, Pfau D, Bryk R, Aubé J, Zimmerman M, Dartois V, Nathan C |
Journal | Proc Natl Acad Sci U S A |
Volume | 122 |
Issue | 12 |
Pagination | e2425309122 |
Date Published | 2025 Mar 25 |
ISSN | 1091-6490 |
Keywords | Animals, Carboxy-Lyases, Cell Death, HSP70 Heat-Shock Proteins, Humans, Intracellular Membranes, Lysosomes, Macrophages, Mice, Mice, Inbred C57BL, Mycobacterium tuberculosis, Permeability, Tuberculosis |
Abstract | Mycobacterium tuberculosis (Mtb) primarily infects macrophages. In vitro without antibiotics, wild-type Mtb hastens death of the macrophages, but the processes leading to rapid cell death are not well understood. Our earlier work indicated that the death of Mtb-infected mouse macrophages in vitro is markedly exacerbated by induction of interferon-β (IFN-β) [L. Zhang et al., J. Exp. Med. 18, e20200887 (2021)]. Here, we identified a key downstream response to IFN-β in the context of Mtb infection as the massive induction of cis-aconitate decarboxylase (ACOD1), not only in its canonical subcellular localization in mitochondria but also in the cytosol, where it bound to the lysosome-stabilizing protein HSP70. ACOD1's product, itaconate, protected Mtb-infected macrophages. However, the contrasting and predominant effect of high-level ACOD1 expression was to act in a noncatalytic manner to promote HSP70's degradation, leading to lysosomal membrane permeabilization (LMP). Mtb-induced macrophage death was markedly diminished by inhibitors of cysteine proteases, consistent with lysosome-mediated cell death. Neither ACOD1 inhibitors nor cysteine protease inhibitors are suitable for potential host-directed therapy (HDT) of tuberculosis. Instead, this work directs attention to how ACOD1 acts nonenzymatically to promote the degradation of HSP70. |
DOI | 10.1073/pnas.2425309122 |
Alternate Journal | Proc Natl Acad Sci U S A |
PubMed ID | 40100622 |
PubMed Central ID | PMC11962489 |
Grant List | Fellowship / / Cancer Research Institute (CRI) / R21AI178133 / / HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID) / R01 AI155510 / AI / NIAID NIH HHS / United States ROIAI155510 / / HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID) / R21 AI178133 / AI / NIAID NIH HHS / United States (no number) / / Abby and Howard P. Milstein Program in Chemical Biology and Translational Medicine / |
Submitted by ljc4002 on August 21, 2025 - 3:43pm